BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21155876)

  • 1. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
    Eisendle K; Müller H; Ortner E; Talasz H; Graziadei I; Vogel W; Höpfl R
    J Gastroenterol Hepatol; 2011 Apr; 26(4):716-21. PubMed ID: 21155876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
    Matsuzaki Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?
    Sinakos E; Lindor KD
    Am J Gastroenterol; 2010 Mar; 105(3):596-8. PubMed ID: 20203641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurov FKh
    Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of pruritus associated with elevated bile acid levels in serum.
    Herndon JH
    Arch Intern Med; 1972 Oct; 130(4):632-7. PubMed ID: 4564854
    [No Abstract]   [Full Text] [Related]  

  • 12. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
    Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels.
    Sjövall J; Sjövall K
    Ann Clin Res; 1970 Dec; 2(4):321-37. PubMed ID: 5493462
    [No Abstract]   [Full Text] [Related]  

  • 15. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on pruritus in obstructive jaundice cases with special references to serum bile acid fractions].
    Mashima H
    Fukuoka Igaku Zasshi; 1991 Aug; 82(8):445-57. PubMed ID: 1937344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy.
    Tribe RM; Dann AT; Kenyon AP; Seed P; Shennan AH; Mallet A
    Am J Gastroenterol; 2010 Mar; 105(3):585-95. PubMed ID: 19904249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.